Celecoxib Plus R-CHOP vs R-CHOP in Newly Diagnosed Advanced CD5+ DLBCL
NCT07494565
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Diffuse Large B-Cell Lymphoma (DLBCL)
CD5 Positive
Interventions
DRUG:
Celecoxib Combined with R-CHOP
DRUG:
R-CHOP
Sponsor
Sun Yat-sen University